Xiaofang Chen

1.5k citations
67 papers · 1.2k indexed · h-index 19

Xiaofang Chen

61 papers receiving 1.2k citations

Peers

Xiaofang Chen
Comparison fields: 5 of 122
  • Cancer Research 282
  • Reproductive Medicine 76
  • Molecular Biology 614
  • Molecular Medicine 36
  • Immunology 150
Replace Dandan Wang with:
Dandan Wang China
Hanna Piotrowska‐Kempisty Poland
Ioana Ilie Romania
Lin Huang China
Nawneet K. Kurrey India
Víctor Ermilo Arana‐Argáez Mexico
Ting Zhong China
Shanshan Yang China
Julio César Torres‐Romero Mexico
Xiaofang Chen relative to Dandan Wang China Dandan Wang's profile →
Citations per field
00.5×1.7×
Dandan Wang · 1×
Citations per year

Countries citing papers authored by Xiaofang Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaofang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Chen more than expected).

Fields of papers citing papers by Xiaofang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Chen. The network helps show where Xiaofang Chen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiaofang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaofang Chen Line = papers co-authored together Xiaofang Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20253
2 20254
3 20250
4 20242
5 20238
6 20232
7 20226
8 20221
9 202115
10 202071
11 202038
12 202018
13 201919
14 20192
15 201820
16 20175
17 20166
18
[Characteristics of hypertension prevalence and related factors in rural area in Sichuan].
20155
19 20159
20 201315

About Xiaofang Chen

Xiaofang Chen is a scholar working on Molecular Medicine, Endocrinology and Cancer Research, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Antibiotic Resistance in Bacteria (4 papers), Heat shock proteins research (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Diet and metabolism studies (3 papers), Legionella and Acanthamoeba research (3 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). The work is most often cited by research in Cancer Research (282 citations), Reproductive Medicine (76 citations) and Molecular Biology (614 citations). Xiaofang Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Christopher C.W. Hughes, Steven C. George, Anna S. Aledia, Xiao-Juan Ye, Yun Liu, Yueqin Liu, Xiaolan Zhu, Wenlin Xu, Yuefeng Li and Yanbin Wu. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Biochemical and Biophysical Research Communications, Molecules and The Journal of Antibiotics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026